JNJ

MKT CAP:$538B

Johnson & Johnson

Market Cap

$538B

Healthcare·Drug Manufacturers - General·🇺🇸 United States·NYSE

Healthcare·Drug Mfg.·🇺🇸·NYSE

Stock Price

$232.16+$27.11 (+13.22%)

Jun 8, 2026

52W High $247.1152W Low $146.12

Company Details

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The In...

CEO

—

IPO Date

Sep 24, 1944

Website

www.jnj.com

Key Metrics TTM

Revenue

$96.4B

+7.9% YoY

Net Income

$21.0B

EPS (Diluted)

Free Cash Flow

$17.8B

Revenue / Share

$39.41

Gross Margin

69.1%

Operating Margin

26.9%

Net Margin

21.8%

FCF Margin

18.5%

P/S

5.6x

P/E

25.6x

Earnings Reports

Q2 2026

Jul 15, 2026

PENDING

Q1 2026

Apr 22, 2026

$24.1B+9.9%

FY 2025

Feb 11, 2026

$94.2B+6.0%

Q4 2025

Feb 11, 2026

$24.6B+9.1%

Q3 2025

Oct 22, 2025

$24.0B+6.8%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee